Across TCGA pan-cancer cohorts, C12orf75 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated C12orf75 data layer compared with 6 for mass-spec protein.
The strongest signal is observed in uveal melanoma (UVM), where higher C12orf75 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated C12orf75 expression acts as an unfavorable survival marker, although some lineages such as BRCA and SKCM show a favorable association.
UVM, LIHC, and BLCA are the cancer types where C12orf75 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.